BeStock  
Stocks › Biotechnology › KYMR

Kymera Therapeutics KYMR

US equityMarket cap rank #1426Biotechnology
$115.31 −$4.08 (-3.42%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $124.06 +7.59%
Open$117.89
Prev close$119.39
Day range$114.40 – $119.60
Volume1.28M
Market cap$9.84B
P/E (TTM)–
Dividend yield–

KYMR Stock News

Headlines matching Kymera Therapeutics or the KYMR ticker, most recent first.

  • J.P. Morgan Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $140 PositiveMarket news · 4 Sep 2026 · Direct mention
  • J.P. Morgan Sticks to Its Buy Rating for Kymera Therapeutics (KYMR)TipRanks · 4 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Maintains Target Price $140Market news · 28 Sep 2026 · Direct mention
  • Piper Sandler Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Maintains Target Price $140Market news · 23 Sep 2026 · Direct mention
  • Stifel Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $152 PositiveMarket news · 22 Sep 2026 · Direct mention
  • BofA Securities Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $144 PositiveMarket news · 14 Sep 2026 · Direct mention
  • Wolfe Research Upgrades Kymera Therapeutics(KYMR.US) to Buy Rating, Announces Target Price $180 PositiveMarket news · 10 Sep 2026 · Direct mention
  • J.P. Morgan Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Announces Target Price $121Market news · 8 Aug 2026 · Direct mention
  • BofA Securities Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Cuts Target Price to $123 NegativeMarket news · 8 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Kymera Therapeutics(KYMR.US), With a Forecast Between $116 to $139Market news · 7 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Kymera Therapeutics(KYMR.US), With a Forecast Between $128 to $139Market news · 6 Aug 2026 · Direct mention
  • Guggenheim Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $170 PositiveMarket news · 31 Aug 2026 · Direct mention
  • Wells Fargo Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Raises Target Price to $151 PositiveMarket news · 27 Aug 2026 · Direct mention
  • Stifel Maintains Kymera Therapeutics(KYMR.US) With Buy Rating, Maintains Target Price $132Market news · 14 Aug 2026 · Direct mention
  • Analysts' Top Healthcare Picks: Metagenomi, Inc. (MGX), Kymera Therapeutics (KYMR)TipRanks · 11 Aug 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on KYMR.

Sign in to join the discussion.

Scroll to Top